Compared groups | Comparison full survey in centres/ selectively referral | Comparison breast/ bowel centres | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Distress items | Group | Degrees of severity (%) | Mean(SD) | ANOVA:F (p) R2 | Group | Degrees of severity (%) | Mean(SD) | ANOVA:F (p) | ||||
Sleep disturbances | To | 30 | 59 | 11 | 1.12 (1.00) | Â | Ce | 32 | 60 | 8 | 1.02 (0.93) | Â |
Ce | 32 | 60 | 8 | 1.02 (0.93) | 7.46 (0.007) | Br | 32 | 61 | 7 | 0.99 (0.89) | 0.44 (0.507) | |
Re | 25 | 56 | 19 | 1.38 (1.14) | 0.03 | Bo | 32 | 57 | 11 | 1.08 (0.99) | ||
Mood swings | To | 22 | 59 | 19 | 1.37 (1.11) | Â | Ce | 25 | 62 | 13 | 1.15 (0.99) | Â |
Ce | 25 | 62 | 13 | 1.15 (0.99) | 33.08 (<0.001) | Br | 22 | 67 | 11 | 1.13 (0.92) | 0.11 (0.740) | |
Re | 14 | 52 | 34 | 1.95 (1.22) | 0.10 | Bo | 30 | 54 | 16 | 1.18 (1.12) | ||
Cognitive impairment | To | 66 | 28 | 6 | 0.56 (0.95) | Â | Ce | 70 | 26 | 3 | 0.45 (0.85) | Â |
Ce | 70 | 26 | 3 | 0.45 (0.85) | 9.78 (0.002) | Br | 75 | 23 | 2 | 0.36 (0.74) | 4.26 (0.042) | |
Re | 54 | 34 | 11 | 0.84 (1.11) | 0.03 | Bo | 62 | 33 | 5 | 0.62 (1.02) | ||
Helplessness/ vulnerability | To | 52 | 40 | 8 | 0.80 (1.01) | Â | Ce | 59 | 36 | 5 | 0.62 (0.89) | Â |
Ce | 59 | 36 | 5 | 0.62 (0.89) | 26.7 (<0.001) | Br | 59 | 38 | 3 | 0.58 (0.84) | 0.66 (0.417) | |
Re | 33 | 49 | 18 | 1.28 (1.15) | 0.08 | Bo | 57 | 34 | 8 | 0.68 (0.98) | ||
Anxiety/worry/ tension | To | 21 | 58 | 21 | 1.53 (1.20) | Â | Ce | 23 | 62 | 16 | 1.33 (1.11) | Â |
Ce | 23 | 62 | 16 | 1.33 (1.11) | 22.9 (<0.001) | Br | 21 | 64 | 15 | 1.30 (1.06) | 0.24 (0.624) | |
Re | 15 | 47 | 38 | 2.06 (1.27) | 0.03 | Bo | 26 | 57 | 17 | 0.69 (0.98) | ||
Shame/loss of esteem | To | 78 | 20 | 2 | 0.27 (0.59) | Â | Ce | 82 | 17 | 0.5 | 0.20 (0.50) | Â |
Ce | 82 | 17 | 0.5 | 0.20 (0.50) | 9.7 (0.002) | Br | 82 | 18 | 0 | 0.20 (0.45) | 0.001 (0.971) | |
Re | 67 | 30 | 3 | 0.44 (0.76) | 0.03 | Bo | 84 | 15 | 1 | 0.21 (0.58) | ||
Depression/grief | To | 28 | 51 | 20 | 1.40 (1.22) | Â | Ce | 33 | 54 | 13 | 1.15 (1.10) | Â |
Ce | 33 | 54 | 13 | 1.15 (1.10) | 35.2 (<0.001) | Br | 33 | 55 | 12 | 1.12 (1.06) | 0.54 (0.463) | |
Re | 15 | 55 | 39 | 2.06 (1.30) | 0.11 | Bo | 33 | 52 | 15 | 1.23 (1.17) | ||
Fatigue | To | 21 | 67 | 12 | 1.24 (0.95) | Â | Ce | 25 | 66 | 9 | 1.09 (0.87) | Â |
Ce | 25 | 66 | 9 | 1.09 (0.87) | 20.8 (<0.001) | Br | 28 | 66 | 6 | 0.97 (0.81) | 7.59 (0.006) | |
Re | 11 | 68 | 20 | 1.64 (1.04) | 0.07 | Bo | 19 | 66 | 15 | 1.32 (0.95) | ||
Pain | To | 40 | 54 | 6 | 0.82 (0.88) | Â | Ce | 45 | 53 | 2 | 0.70 (0.77) | Â |
Ce | 45 | 53 | 2 | 0.70 (0.77) | 17.3 (<0.001) | Br | 46 | 53 | 1 | 0.65 (0.69) | 1.81 (0.180) | |
Re | 27 | 58 | 15 | 1.16 (1.04) | 0.06 | Bo | 42 | 53 | 4 | 0.79 (0.89) | ||
Functional limitations | To | 37 | 48 | 15 | 1.13 (1.15) | Â | Ce | 46 | 46 | 9 | 0.86 (1.01) | Â |
Ce | 46 | 46 | 9 | 0.86 (1.01) | 52.3 (<0.001) | Br | 56 | 40 | 4 | 0.63 (0.87) | 22.3 (<0.001) | |
 | Re | 15 | 54 | 31 | 1.87 (1.20) | 0.15 | Bo | 26 | 57 | 17 | 1.29 (1.11) |  |